This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 3 EPO patents. Top assignee: Immunogen, Inc.. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2022
Title: Innovations by Deborah H Meshulam
Introduction
Deborah H Meshulam is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of drug development, holding a total of 5 patents. Her work focuses on creating innovative processes for preparing drug conjugates that enhance therapeutic efficacy.
Latest Patents
One of her latest patents is titled "Process for preparing purified drug conjugates." This invention provides a detailed methodology for preparing a cell-binding agent that is chemically coupled to a drug. The process involves covalently attaching a linker to a cell-binding agent, followed by a purification step, conjugating a drug to the cell-binding agent, and a subsequent purification step. This innovative approach aims to improve the effectiveness of drug delivery systems.
Career Highlights
Deborah H Meshulam is currently associated with Immunogen, Inc., where she continues to advance her research and development efforts. Her expertise in drug conjugates has positioned her as a key figure in the pharmaceutical industry, contributing to the development of targeted therapies.
Collaborations
Throughout her career, Deborah has collaborated with notable colleagues, including Yong Dai and Yong Wang. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in drug development.
Conclusion
Deborah H Meshulam's contributions to the field of drug conjugates exemplify her commitment to innovation and excellence in pharmaceutical research. Her work continues to impact the industry positively, paving the way for future advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
